Side effects of Alizapride in details
Psychiatric disorders and central nervous system: Extrapyramidal symptoms, which can occur especially in children and young adults, even after a single dose of the medicine (acute and tardive dystonia, parkinsonian syndrome, akathisia).
Tardive dyskinesia in the case of prolonged treatment. Somnolencia, mareo, cefalea, insomnio. Drowsiness, dizziness, headache, insomnia.
Gastrointestinal disorders: Diarrhoea.
Endocrine disorders: amenorrhea, galactorrhea, gynecomastia, hyperprolactinemia. General disorders: allergic reactions, including anaphylaxis.
Alizapride contraindications
Alizapride or hypersensitivity to any component of the formula.
Patients with a history of tardive dyskinesia with the use of neuroleptics.
Patients with known or suspected pheochromocytoma.
References
- European Chemicals Agency - ECHA. "Alizapride: The information provided here is aggregated from the "Notified classification and labelling" from ECHA's C&L Inventory. ". https://echa.europa.eu/information-o... (accessed September 17, 2018).
- KEGG. "Target-based classification of drugs". http://www.genome.jp/kegg-bin/get_ht... (accessed September 17, 2018).
- WHO ATC. "ATC Code: In the World Health Organization (WHO) Anatomical Therapeutic Chemical (ATC) classification system, the active substances are divided into different groups according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.". https://www.whocc.no/atc_ddd_index/ (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Alizapride are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Alizapride. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported side effects
No survey data has been collected yetConsumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
